Is 2C-T-7 legal in New Zealand?
- Legal status
- Controlled through the open analogue limb rather than by a schedule name. 2C-T-7, a sulfur-substituted 2C-series phenethylamine, has no entry of its own in Schedules 1 to 3 on the text cited, and this finding does not rest on that absence: the Misuse of Drugs Act 1975 defines a controlled drug analogue as any substance whose structure is substantially similar to that of a controlled drug, subject to the stated exclusions, and the stated parent structure places 2C-T-7 in that limb unless a medicine exclusion or an express exclusion applies. The analogue route lands in Schedule 3 Part 7, so the class is C. The sulfur substitution does not take it out of the analogue limb, which asks about substantial structural similarity rather than about any one atom. The dossier states the statutory route rather than claiming a laboratory determination, because a court-grade analogue conclusion can depend on expert structural evidence. The consolidation read was the one current at 20 September 2026, with the Order of 2025 commenced on 27 November 2025 as the latest instrument actually in force.
- Consequences if caught
- Capital exposure: none. New Zealand has no death penalty. A controlled drug analogue is treated as a Class C controlled drug, so the exposure on 2C-T-7 is the section 6 dealing maximum of 8 years, with section 7 reaching possession. This row's own ceiling column states the section 7 limb without attaching a figure to it, and the Class C rows in this table put that possession maximum at 3 months. The 8 year figure is the whole of the exposure on this route. The figure does not move with the sulfur substitution, because the limb asks a similarity question rather than an atom by atom one.
- If prescribed or medical
- Not established for a traveller. This dossier carries no country-level rule for entering New Zealand with a prescribed medicine: it records that medicines status has to be checked alongside the analogue exclusions and the Psychoactive Substances Act 2013 route, and that a court-grade conclusion can turn on the medicine exclusions, but it states no declaration requirement, no permit, no quantity allowance and no carry limit at the border, and none was researched for this cell. What is established is the placement a traveller would be read against: 2C-T-7 is not named in Schedules 1 to 3 and is reached, if at all, through the section 2 controlled-drug-analogue limb, which is treated as Class C. No prescribed form is in view, and the placement depends on a structural comparison that only expert evidence settles. Do not read that placement as a ruling on a lawfully prescribed and lawfully carried supply, which is a different question this cell does not answer. Settle the border question with the Ministry of Health, whose classification order implementation page this dossier cites, and with the New Zealand border authority, before travelling.
- Documentation
- Carry the Misuse of Drugs Act 1975 consolidation current at 20 September 2026 and read section 2 together with Schedule 3 Part 7, because neither carries the finding for 2C-T-7 on its own. Read the words substantially similar in the section 2 definition, because that phrase and not a list is what reaches 2C-T-7. Carry the point that an absent name is not an answer in New Zealand: the list is closed for named substances while the analogue limb is open, so a search of the schedules that returns nothing has not finished the question. Carry the classification chain this finding was read against as well: the 2022 and 2025 Classification and Presumption of Supply Orders with their commencement orders, the 2024 pseudoephedrine amendment, and the 2026 Order, which was made but is not treated as law in this dossier because its own section 2 leaves commencement to the Governor-General and no commencement instrument was located by the horizon. Carry the date as well, 20 September 2026, because in New Zealand a classification order can move a substance between classes without a word of the Act changing.
- Misuse of Drugs Act 1975, Schedules 1 to 5, at https://www.legislation.govt.nz/act/public/1975/116/en/latest/, read as at 20 September 2026. The power that moves the list is section 4, which authorises the Governor General by Order in Council to amend Schedules 1 to 5 subject to statutory approval and commencement machinery, so the schedules are not fixed by the Act's own date. The chain the source records as checked is the current consolidation, the 2022 and 2025 Classification and Presumption of Supply Orders with their commencement orders, and the 2024 pseudoephedrine amendment. A 2026 Order exists and the source records it as uncommenced at that date, so this reading does not rule out a later amendment that had commenced or been made after it. The published URL resolves to the latest consolidation rather than to a fixed version, so the read date above is what identifies the text, not the link.
Court records
We have not yet assessed whether court records are publicly available for this jurisdiction.
2C-T-7 in related jurisdictions
Other substances confirmed in New Zealand
Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with New Zealand’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.
Before you travel
Verify current rules with the destination country’s official drug authority and your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.
If you’re detained or arrested abroad
Contact your own country’s embassy or consulate in the destination immediately, not the destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →
